Placebo-Controlled Study of Mometasone Furoate Nasal Spray (MFNS) 200 Mcg QD in the Treatment of Seasonal Allergic Rhinitis.
Phase of Trial: Phase III
Latest Information Update: 21 May 2014
At a glance
- Drugs Mometasone (Primary)
- Indications Seasonal allergic rhinitis
- Focus Therapeutic Use
- Sponsors Schering-Plough
- 21 Jun 2010 Actual end date (Jul 2007) added as reported by ClinicalTrials.gov.
- 21 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 May 2007 New trial record.